#Bridge2024
Prof Paolo Ascierto #Melanoma #Immunotherapy ROCKSTAR Istituto Nazionale IRCCS Fondazione “G Pascale” talks about salvage therapy post 1st line failure #Bridge2024 @sitcancer.bsky.social @PAscierto
December 7, 2024 at 3:52 PM
Prof Hussein Tawbi #melanoma #Immunotherapy guru @mdanderson.bsky.social talks evolution of first line therapy. Highlights #LAG3 & lays out summary of what may be optimal for first line therapy & what looks promising/ #PD1 #CTLA4 #nivo #Ipi @bmsnews.bsky.social
#BRIDGE2024 @sitcancer.bsky.social
December 7, 2024 at 3:45 PM
#Bridge2024 coming to a close! Saturday, December 7th 2024 @2:10 pm and we are entering the last session/will cover 1st line #immunotherapy, salvage, igniting change in #cancer #vaccine development, combo IO, #PD1 refractory & more @sitcancer.bsky.social #MSD #BIOTECH #BMS #Merck #Regeneron #UbiVac
December 7, 2024 at 1:26 PM
2) Prof Tullia Bruno #B Cell GURU @ #UPMC reviews #TLS & then dives into “DO NOT POST” differences in TLS btwn #melanoma & #LungCancer brain #metastases / #Bridge2024 @sitcancer.bsky.social @robertferrismdphd.bsky.social #FinishCancer
December 7, 2024 at 11:29 AM
Prof Tullia Bruno #B_Cell GURU @ #UPMC reviews #TLS & then dives into “DO NOT POST” differences in TLS btwn #melanoma & #LungCancer brain #metastases /soon 2 b submitted/ #Bridge2024 @sitcancer.bsky.social @robertferrismdphd.bsky.social #FinishCancer
December 7, 2024 at 11:26 AM
3) Dr Allison Betof Warner @DrBetofMDPHD #Stanford talks #TIL /The 96% 10 yr survival of TIL pts achieving CR needs us to understand better/the Need for Biopsy
#Bridge2024 #FinishCancer @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #MRF @sitcancer.bsky.social
December 7, 2024 at 10:52 AM
December 7, 2024 at 10:48 AM
December 7, 2024 at 10:47 AM
Prof James Smithy #cancer #immunotherapy expert @mskcc.bsky.social talks #CPI 2.0 / lots of data/ some discussing + signals in combo studies/some highlights here #Bridge2024 @sitcancer.bsky.social #BMS #merck #Regeneron
December 7, 2024 at 10:34 AM
2) Prof Oliver Michelin #spatiomics expert @ Univ de #Geneve & #Swiss #Cancer Center talks graph based methods to assess cell infiltrates. Most data “DO NOT POST” #JoeYeong #JEDIcouncil #Bridge2024 @sitcancer.bsky.social #multiomics @aruthak.bsky.social #USCAP #AI #DigitalPathology #FinishCancer
December 7, 2024 at 10:14 AM
Prof Oliver Michelin #spatiomics expert @ Univ de #Geneve & #Swiss #Cancer Center talks graph based methods to assess cell infiltrates. Most data “DO NOT POST” #JoeYeong #JEDIcouncil #Bridge2024 @sitcancer.bsky.social #multiomics @aruthak.bsky.social #USCAP #AI #DigitalPathology #FinishCancer
December 7, 2024 at 10:11 AM
December 7, 2024 at 9:51 AM
December 7, 2024 at 9:49 AM
3) Prof @Jeffrey Gerschenwald #melanoma & #cancer staging Guru @mdanderson.bsky.social talks Evidence-based changes to #AJCC 8th edition staging manual #Bridge2024 @sitcancer.bsky.social
December 7, 2024 at 9:46 AM
2) Prof @Jeffrey Gerschenwald #melanoma & #cancer staging Guru @mdanderson.bsky.social talks Evidence-based changes to #AJCC 8th edition staging manual #Bridge2024 @sitcancer.bsky.social
December 7, 2024 at 9:46 AM
1) Prof @Jeffrey Gerschenwald #melanoma & #cancer staging Guru @mdanderson.bsky.social talks Evidence-based changes to #AJCC 8th edition staging manual #Bridge2024 @sitcancer.bsky.social
December 7, 2024 at 9:44 AM
1) Prof @Jeffrey Gerschenwald #melanoma & #cancer staging Guru @mdanderson.bsky.social talks Evidence-based changes to #AJCC 8th edition staging manual #Bridge2024 @sitcancer.bsky.social
December 7, 2024 at 9:43 AM
Prof. Alexander Eggermont #melanoma #immunotherapy expert argues in stage I-II Patients the CP-GEP #biomarker on FFPE identifies relapsing patients that should be candidates for systemic therapy @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #BRIDGE2024 #USCAP
December 7, 2024 at 9:28 AM
10) GREAT DEBATE!! #Artificial #intelligence ( #AI ) vs human #paghology/ Prof. Carlo Bifulco @chilesResearch takes on Prof. Janis Taube #Hopkins #Pathology To start- 91% agree with Carlo - AI is better/Dr. Taube changes lots of peoples perspective! #Bridge2024 @sitcancer.bsky.social
December 6, 2024 at 6:13 PM
9) GREAT DEBATE!! #Artificial #intelligence ( #AI ) vs human #paghology/ Prof. Carlo Bifulco @chilesResearch takes on Prof. Janis Taube #Hopkins #Pathology To start- 91% agree with Carlo - AI is better . #Bridge2024 @sitcancer.bsky.social
December 6, 2024 at 6:11 PM
8) GREAT DEBATE!! #Artificial #intelligence ( #AI ) vs human #paghology/ Prof. Carlo Bifulco @chilesResearch takes on Prof. Janis Taube #Hopkins #Pathology To start- 91% agree with Carlo - AI is better . #Bridge2024 @sitcancer.bsky.social
December 6, 2024 at 6:10 PM
7) GREAT DEBATE!! #Artificial #intelligence ( #AI ) vs human #paghology/ Prof. Carlo Bifulco @chilesResearch takes on Prof. Janis Taube #Hopkins #Pathology To start- 91% agree with Carlo - AI is better . #Bridge2024 @sitcancer.bsky.social
December 6, 2024 at 6:08 PM
6) Dr Taube starts: GREAT DEBATE!! #Artificial #intelligence ( #AI ) vs human #paghology/ Prof. Carlo Bifulco @chilesResearch takes on Prof. Janis Taube #Hopkins #Pathology To start- 91% agree with Carlo - AI is better . #Bridge2024 @sitcancer.bsky.social
December 6, 2024 at 6:04 PM
5) Carlo’s last slide / GREAT DEBATE!! #Artificial #intelligence ( #AI ) vs human #paghology/ Prof. Carlo Bifulco @chilesResearch takes on Prof. Janis Taube #Hopkins #Pathology To start- 91% agree with Carlo - AI is better . #Bridge2024 @sitcancer.bsky.social
December 6, 2024 at 6:03 PM
4) GREAT DEBATE!! #Artificial #intelligence ( #AI ) vs human #paghology/ Prof. Carlo Bifulco @chilesResearch takes on Prof. Janis Taube #Hopkins #Pathology To start- 91% agree with Carlo - AI is better . #Bridge2024 @sitcancer.bsky.social
December 6, 2024 at 6:01 PM